Mechanisms of protection against pulmonary hyperbaric O(2) toxicity by intermittent air breaks.
Intermittent exposure to air is used as a protective strategy against hyperbaric O(2) (HBO(2)) toxicity. Little is known about optimal intermittent exposure schedules and the mechanism of protection. In this study, we examined the role of antioxidant enzymes, and inflammatory cytokines in the mechanism of HBO(2) tolerance by intermittent air breaks. One group of rats was exposed continuously to 282 kPa O(2) until death. Other groups were exposed to 30, 60, and 120 min intervals of HBO(2) with different numbers of intermittent 30 min air breaks (1-12 breaks). After the final break, animals were exposed to HBO(2) until death. In a separate experiment, animals were sacrificed before terminal exposure and lung tissues were collected for analysis of gene expression. Two intermittent schedules with 6 h cumulative O(2) time (30/30 and 60/30 min schedules) were compared with continuous exposure to HBO(2) for 6 h and with intermittent exposure of 8 h (120/30 min schedule) duration. Continuous exposure resulted in activation of inflammatory cytokine TNF-alpha and IL-1beta mRNA expression, an increase in lung protein nitration and activation of inducible NOS (iNOS) mRNA. Inflammatory response was not observed at intermittent exposures of the same cumulative O(2) time duration (30/30 and 60/30 min schedule). Expression of heme oxygenase-1 (HO-1) mRNA was significantly increased in all exposure groups while manganese superoxide dismutase (MnSOD) mRNA expression was increased only in continuous and 120/30 exposure groups. Results show that intermittent exposure to air protects against pulmonary HBO(2) toxicity by inhibiting inflammation. The mechanism of inhibition may involve the antiinflammatory and antioxidative effect of HO-1 but some other mechanisms may also be involved in protection by intermittent air breaks.
Chavko
Mikulas
M
Trauma and Resuscitative Medicine Department, Naval Medical Research Center, 503 Robert Grant Avenue, Silver Spring, MD 20910, USA. chavkom@nmrc.navy.mil
Mahon
Richard T
RT
McCarron
Richard M
RM
D000388:Air; D000818:Animals; D015153:Blotting, Western; D015870:Gene Expression / Q000502:physiology; D051547:Heme Oxygenase-1 / Q000378:metabolism; D006931:Hyperbaric Oxygenation / Q000009:adverse effects* / Q000379:methods*; D007700:Kinetics; D008168:Lung / Q000378:metabolism; D008297:Male; D052247:Nitric Oxide Synthase Type II / Q000096:biosynthesis / Q000235:genetics; D010100:Oxygen / Q000008:administration & dosage / Q000633:toxicity*; D010101:Oxygen Consumption / Q000502:physiology; D012333:RNA, Messenger / Q000096:biosynthesis / Q000235:genetics; D051381:Rats; D017207:Rats, Sprague-Dawley; D020133:Reverse Transcriptase Polymerase Chain Reaction; D013482:Superoxide Dismutase / Q000378:metabolism; D014443:Tyrosine / Q000031:analogs & derivatives / Q000378:metabolism
D012333:RNA, Messenger; C002744:3-nitrotyrosine; D014443:Tyrosine; D052247:Nitric Oxide Synthase Type II; D051547:Heme Oxygenase-1; D013482:Superoxide Dismutase; D010100:Oxygen